INOFEA AG

Enzyme-based solutions for the synthesis of biologics such as mRNA vaccines, therapeutics and ADCs, as well as for biocatalytic process steps in small-molecule APIs.

Ready-to-use and pipeline products from the enzyme portfolio, including Protease Kit, Carboxypeptidase Y, Leucine aminopeptidase, Prolidase, Pronase, Proteinase K, RNA Polymerase, DNase I and S1 Nuclease.

Project analysis, feasibility study, development and production of formulated enzymes, as well as custom solutions for new products and enzyme-mediated chemical processes.

Patented technology for the immobilization and shielding of enzymes, with separation after the reaction, prevention of leaching, and use in batch, flow and continuous processes.

Applications for the enzymatic manufacture of biologics, including mRNA and ADCs, with a focus on specificity, mild reaction conditions, high precision and improved purification.